Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1990-09-20
1992-05-12
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
424484, 424486, 514928, 514941, 514969, 514626, A61K 906, A61K 4732, A61K 4734, A61K 31575
Patent
active
051126206
ABSTRACT:
A therapeutic ointment having wet adherent properties and particularly well suited for delivery of medicaments to mucosal surfaces includes a base material comprising from about 3 to 15% by weight of a water soluble salt of a copolymer of methyl vinyl ether and maleic acid or anhydride in a polyethylene glycol ointment. Formulations of the base material with triamcinolone acetonide and lidocaine are particularly efficacious in the treatment of recurrent aphthous ulcers.
REFERENCES:
patent: Re33093 (1989-10-01), Schiraldi et al.
patent: 4307075 (1981-12-01), Martin
patent: 4627977 (1986-12-01), Gaffar et al.
patent: 4764378 (1988-08-01), Keith et al.
patent: 4765983 (1988-08-01), Takayanagi et al.
patent: 4883660 (1989-11-01), Blackman et al.
patent: 4910247 (1990-03-01), Haldar et al.
patent: 4948580 (1990-08-01), Browning
"Topical Mucosal Adhesive Dosage Forms", T. Nagi, Medicinal Research Reviews, vol. 6, No. 2, 227-242 (1986).
Gerding Thomas G.
Repka Michael A.
Eberhardt Wayne R.
Mikkur, Inc.
Page Thurman K.
Webman E. J.
LandOfFree
Polyethylene glycol ointment for apthous ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyethylene glycol ointment for apthous ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyethylene glycol ointment for apthous ulcers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2425766